New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
Go back to New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection| (NASDAQ: PSNL) | Delayed: 16.40 +0.17 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.23 | 52 Week High | $ | |||
| Open | $16.30 | 52 Week Low | $ | |||
| Day High | $16.44 | P/E | N/A | |||
| Day Low | $16.12 | EPS | $ | |||
| Volume | 3,180,446 | |||||
